Octreotide
Octreotide is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand name including Mycapssa. Available dosage forms: powder, capsule, delayed release.
Drug details
- Generic Name
- Octreotide
- Brand Names
- Mycapssa
- Application Number
- NDA208232
- Sponsor
- Bachem Americas, Inc.
- NDC Codes
- 7
- Dosage Forms
- POWDER, CAPSULE, DELAYED RELEASE
- Routes
- ORAL
- Active Ingredients
- OCTREOTIDE ACETATE, OCTREOTIDE
Indications and Usage
1 INDICATIONS AND USAGE MYCAPSSA is indicated for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. MYCAPSSA is a somatostatin analog indicated for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide ( 1 ).